Blonanserin

CAS: 132810-10-7

Ref. 3D-FB18840

Informação sobre produto

• Nome: Blonanserin
• Sinónimos: LonasenAD 54232-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-cycloocta[b]pyridine, 2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine, 2-(4-Ethyl-1-piperazinyl)-4-(p-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine, 2-(4-Ethylpiperazin-1-Yl)-4-(4-Fluorophenyl)-5,6,7,8,9,10-Hexahydrocycloocta[B]Pyridine, Ad 5423, Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(1-fluorophenyl)-5,6,7,8,9,10-hexahydro-, Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-, Lonasen
• CAS: 132810-10-7

Descrição

Blonanserin is a drug for the treatment of congestive heart failure. It is a potent and selective antagonist of 5-HT2A receptors. Blonanserin was shown to increase serum prolactin levels in humans, and has been shown to decrease locomotor activity in rats. The effects on locomotor activity are not due to its effect on dopamine or serotonin levels, but may be caused by its matrix effect on 5-HT2A receptors. The long-term efficacy of blonanserin has been demonstrated by the fact that it can be used as a pharmacological treatment for Parkinson's disease and schizophrenia.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 367.5 g/mol
• Fórmula: C₂₃H₃₀FN₃
• Pureza: Min. 95%
• InChI: InChI=1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3
• Chave InChI: InChIKey=XVGOZDAJGBALKS-UHFFFAOYSA-N
• SMILES: CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1